Nir Naor joins Neuronetics as CFO on July 23, 2026, receiving 500,000 restricted shares as part of the appointment.
Neuronetics (STIM) appointed Nir Naor as chief financial officer, effective July 23, 2026. Naor will receive 500,000 restricted shares as an employment inducement.
Naor brings over 20 years of finance and life sciences experience, most recently serving as CFO of Axogen (AXGN). His appointment follows a career in financial leadership within the sector.
The company did not disclose immediate market reaction to the announcement.